← Open Payments lookup

SAAD KHAN: Open Payments

NPI 1093707218 · CREVE COEUR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,612 in 145 payments from 18 companies in 2025. Trend: 2023 $2,805 · 2024 $2,639 · 2025 $2,612

Food & beverage: $2,612
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.17$283
Neurocrine BioSciences, Inc.16$280
Otsuka America Pharmaceutical, Inc.14$271
Alkermes, Inc.13$251
ABBVIE INC.9$198
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$191
Axsome Therapeutics, Inc.9$171
Teva Pharmaceuticals USA, Inc.10$149
Corium, LLC9$143
Lundbeck LLC5$124

Products named: REXULTI, FANAPT, INGREZZA, ARISTADA, VRAYLAR, CAPLYTA, Auvelity, Azstarys.

Industry payments across MO — which companies pay providers there.